I am ex MSB holder and my call upon the initial FDA CRL remains ... no consistency no children getting inconsistent potency of therapy period. A platform killer that continues into a 2nd CRL without consistency issue being sorted.
MESO Nasdaq update, page-4475
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.46 |
Change
0.065(4.66%) |
Mkt cap ! $1.684B | |||
| Open | High | Low | Value | Volume |
| $1.41 | $1.50 | $1.40 | $5.526M | 3.824M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 473 | $1.61 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.39 | 17979 | 5 |
View Market Depth
| Last trade - 15.59pm 11/11/2024 (20 minute delay) ? |
| MSB (ASX) Chart |